Stada expands its European treatment portfolio
Company adds a number of additional brands from Sanofi following initial take overs in 2021
Read More
Tag: European
Sanofi creates European drug ingredients business
When completed, the planned company will allegedly rank as the world’s second largest API company with approximately €1 billion in expected sales by 2022.
Read More
Libtayo bags EU approval for skin cancer
The European Commission has granted conditional marketing authorisation for the drug for patients who are not candidates for curative surgery or curative radiation.
Read More
European approval for Teva’s migraine drug Ajovy
The drug is a pre-filled syringe for the prophylaxis of migraine in adults who have at least four migraine days per month.
Read More
- UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
- Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
